D2G Oncology

Back To Portfolio D2G Oncology Website Headquarters: Palo Alto, CA Deal Team: Lou Lange Relating drugs to genotypes to transform precision cancer therapeutics. AMV AMV is a venture capital firm investing inearly-stage digital health, technology andlife sciences...

Biogen Idec

Back To Portfolio Biogen Idec FollowFollowFollowFollow Website Headquarters: Cambridge, MA Public: Nasdaq: BIIB, Nasdaq 100, S&P 500 Dedicated to developing new therapies to improve the lives of patients with neurological, autoimmune and hematological disorders...

BiPar Sciences

Back To Portfolio BiPar Sciences Follow Website Headquarters: San Francisco, CA Acquisition: Sanofi Developer of PARP inhibitors as cancer therapies AMV AMV is a venture capital firm investing inearly-stage digital health, technology andlife sciences companies. 2595 E...

Chimerix

Back To Portfolio Chimerix FollowFollow Website Headquarters: Durham, NC Public: Nasdaq: CMRX Deal Team: Skip Fleshman Developing and commercializing novel antiviral therapeutics in areas of high unmet medical need AMV AMV is a venture capital firm investing...

CV Therapeutics

Back To Portfolio CV Therapeutics Website Headquarters: Palo Alto, CA Acquisition: Gilead Sciences Molecular cardiology and drug discovery AMV AMV is a venture capital firm investing inearly-stage digital health, technology andlife sciences companies. 2595 E Bayshore...